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The Forkhead transcription factor FOXP2 is implicated in speech perception and
production. The avian homolog, FoxP21 contributes to song learning and production
in birds. In human cell lines, transcriptional activity of FOXP2 requires homo-dimerization
or dimerization with paralogs FOXP1 or FOXP4. Whether FoxP dimerization occurs in
the brain is unknown. We recently showed that FoxP1, FoxP2 and FoxP4 (FoxP1/2/4)
proteins are co-expressed in neurons of Area X, a song control region in zebra finches.
We now report on dimer- and oligomerization of zebra finch FoxPs and how this affects
transcription. In cell lines and in the brain we identify homo- and hetero-dimers, and an
oligomer composed of FoxP1/2/4. We further show that FoxP1/2 but not FoxP4 bind to
the regulatory region of the target gene Contactin-associated protein-like 2 (CNTNAP2).
In addition, we demonstrate that FoxP1/4 bind to the regulatory region of very low density
lipoprotein receptor (VLDLR), as has been shown for FoxP2 previously. Interestingly,
FoxP1/2/4 individually or in combinations regulate the promoters for SV40, zebra finch
VLDLR and CNTNAP2 differentially. These data exemplify the potential for complex
transcriptional regulation of FoxP1/2/4, highlighting the need for future functional studies
dissecting their differential regulation in the brain.
Keywords: FoxP2, FoxP1, FoxP4, protein interactions, transcription factors, speech, forkhead transcription
factors, zebra finch
INTRODUCTION
Forkhead box (Fox) transcription factors comprise 19 highly evolutionary conserved, structurally
related families, FoxA to FoxS. The defining feature of these genes is the Fox domain which binds
to regulatory regions of target genes. Many Fox genes perform tissue specific functions during
development and mutations can cause cancer and other diseases (Hannenhalli and Kaestner, 2009).
The FoxP family consists of only one member in invertebrates (Santos et al., 2011). Gene
duplication gave rise to four FoxP subfamily members in vertebrates, FoxP1 to FoxP4 (Song et al.,
2016). Expression of these four proteins is specific to particular organs and cell types, with partly
overlapping patterns (Lu et al., 2002; Ferland et al., 2003; Mendoza et al., 2015; Spaeth et al., 2015).
FoxP1/2/4 are all expressed in the brain (Lu et al., 2002; Teufel et al., 2003), whereas FoxP3 is
1Following nomenclature proposed by Kaestner et al. (2000). FOXP refers to the human gene, Foxp refers to the mouse
gene and FoxP refers to all other species.
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prominently expressed in T regulatory cells of the immune
system (Huehn et al., 2009).
In humans, FOXP1 and FOXP2 mutations impair speech
production and perception (Bacon and Rappold, 2012).
FoxP1 has also been linked to autism spectrum disorder (ASD;
Girirajan et al., 2011; Bowers and Konopka, 2012). A human
FOXP4 mutation was associated with developmental delay, heart
and larynx problems (Charng et al., 2016).
We study FoxP proteins in songbirds because birdsong and
speech share many features (Doupe and Kuhl, 1999). Humans
and songbirds learn a large fraction of the sounds they use to
communicate through auditory-guided vocal imitation. Vocal
production learning of speech and birdsong is constrained by
innate predispositions, speech and song learning is best achieved
during critical developmental periods and strongly affected by
social factors. Birdsong and speech depend on analogous neural
pathways that are functionally lateralized (Petkov and Jarvis,
2012; Pfenning et al., 2014). Because of the many parallels
between the development of birdsong and speech, songbirds
provide a genuine model for behavioral, neural and molecular
analyses of genes in the context of vocal communication (Bolhuis
et al., 2010). Temporally and spatially precise manipulations
of FoxP2 amounts in striatal nucleus Area X, a basal ganglia
component of the neural circuit controlling song production
and song learning, results in incomplete and inaccurate vocal
imitation, alters adult song production, spine density and neural
transmission (Haesler et al., 2007; Schulz et al., 2010; Murugan
et al., 2013; Heston and White, 2015). The impact of FoxP1 and
FoxP4 manipulations on song learning has not been reported,
but both FoxPs can co-occur with FoxP2 in the medium spiny
neurons (MSNs) of Area X (Mendoza et al., 2015).
Mice with homozygous deletions of Foxp1, Foxp2 alone or in
combination, or of Foxp4, die before or shortly after birth (Li
et al., 2004b; Wang et al., 2004; Shu et al., 2005, 2007; Rousso
et al., 2012). Heterozygous mutations in mice are associated with
deficits in synaptic function, motor behaviors (Groszer et al.,
2008; French and Fisher, 2014; Fröhlich et al., 2017) and impact
the development and adult production of ultrasonic vocalizations
(Castellucci et al., 2016; Chabout et al., 2016). Foxp4 mouse
mutants have numerous brain and spinal cord defects (Rousso
et al., 2012).
Drosophila melanogaster with FoxP mutations or with RNAi
mediated manipulations of FoxP expression exhibit deficits in an
odor-based decision paradigm (DasGupta et al., 2014), in motor
coordination and courtship song (Lawton et al., 2014), and in
operant self learning (Mendoza et al., 2014).
Among the Fox family of transcription factors, the members
of the P subfamily are unique in their requirement to bind
to another FoxP protein for transcriptional regulation. Both
homo- and hetero-dimerization can occur, mediated by two
evolutionary conserved protein domains, the zinc-finger and
leucine-zipper (Wang et al., 2003; Li et al., 2004a; Mozzi
et al., 2016). A recent study reported episodic positive selection
around the leucine-zipper of FoxP2 in specific avian lineages
with possible consequences for dimerization (Mozzi et al.,
2016). Dimerization of FoxP proteins has so far only been
assessed by overexpressing the mouse (Li et al., 2004a) and
human (Sin et al., 2015) protein versions in cell lines. The
relevance of FoxP protein-protein interaction is emphasized by
the fact that FOXP3 mutations in the dimerization domain cause
IPEX syndrome (Immune dysregulation, polyendocrinopathy,
enteropathy, X-linked human syndrome; Li et al., 2007).
Furthermore, a polymicrogyria patient with a mutation in the
leucine zipper region of FOXP2 showed dysregulation of one of
its target genes, SRXP2 (Roll et al., 2010).
Despite the fact that FoxP factors have the capacity to
dimerize in cell lines (Li et al., 2004a; Sin et al., 2015), it is not
known whether this interaction also takes place in the vertebrate
brain. Overlapping expression of two or more FoxP members
occur in the brain of various vertebrates (Teramitsu et al., 2004;
Takahashi et al., 2008; Rodenas-Cuadrado et al., 2014; Bowers
et al., 2014; Whitney et al., 2015) but few studies have analyzed
co-expression at single cell resolution (Bowers et al., 2014;
Mendoza et al., 2015; Whitney et al., 2015). In mice, Foxp2 and
Foxp4 are co-expressed in spinal cord motor neuroblasts, and
the quantity of Foxp4 protein expressed in those neurons is
important for their differentiation (Rousso et al., 2012). In the rat
the majority of MSNs co-express Foxp1/2 (Bowers et al., 2014). In
the zebra finch FoxP1/2/4, are expressed in specific brain regions
with different degrees of overlap (Mendoza et al., 2015). In Area
X, FoxP1/2/4 are co-expressed in a large fraction of striatal MSN,
but all other combinations of co-expression also exist to different
extents in this cell type (Mendoza et al., 2015). In budgerigar
birds FoxP1/2 also co-localize in the majority of striatal MSN
(Whitney et al., 2015). These findings indicate that interactions
among the FoxP proteins are possible but do not show that they
actually take place.
The aim of this study was to assess whether FoxP1/2/4 of
the zebra finch can dimerize in cell lines and in the brain.
Furthermore, we asked whether FoxP1 and FoxP4 are able
to bind to regulatory regions of two neurally relevant genes,
very low density lipoprotein receptor (VLDLR), encoding one
of the reelin receptors, and Contactin-associated protein-like 2
(CNTNAP2) gene which codes for a neurexin called CASPR2
(Rodenas-Cuadrado et al., 2014). Both proteins were previously
recognized to be regulated by FoxP2 (Spiteri et al., 2007; Vernes
et al., 2007, 2008; Adam et al., 2016). Finally we survey the
transcriptional regulation of FoxPs expressed individually or
in combination, to explore whether homo-dimers and hetero-
dimers fulfill different functions. Our results provide the first
evidence for molecular interactions of FoxP subfamily members
in the brain. We also show that different combinations of
FoxP proteins regulate target genes differentially. These findings
underscore the need to take these interactions into account in
future studies that address why FOXP1 and FOXP2 mutations




Male zebra finches (Taeniopygia guttata) were bred in our colony
at the Freie Universität Berlin. All procedures were performed
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according to the guidelines of the governmental law (TierSchG),
under permits granted by the local Berlin authorities governing
research involving animals. All birds were sacrificed with an
Isoflurane overdose.
Co-Immunoprecipitation (Co-IP)
Co-Immunoprecipitation (Co-IP) was done using Dynabeadsr
Protein G (Invitrogen, Cat.No.100.04D) following the
manufacturer’s protocol with a few changes as follows. We
first incubated the antibody-Dynabeads mixture for 15 min
at room temperature (for antibody concentrations refer to
Table 1). We subsequently incubated the protein extracts plus
antibody-coated Dynabeads mixture for 30 min at 4◦C with
rotation. We eluted with 20 µl of elution buffer (50 mM Glycin
pH 2.8) and before a second round of immunoprecipitation,
we neutralized the elution buffer by adding 4.8 µl 1 M TrisHCl
pH 7.5 and then added washing buffer to bring the volume to a
total of 200 µl. After elution we added 15 µl of 2× Laemmli and
prepared lysates for denaturing conditions.
Western Blots and Detection
Transfected HeK293 cells were treated with M-PER (Thermo
Scientific, Prod#78505) lysis medium for 15 min on ice.
Extracts were centrifuged for 10 min at 1500 g and supernatant
was stored at −80◦C until used. Cell extracts and co-IP’ed
proteins were separated by SDS PAGE (8%–10%), transferred
to a polyvinylidene fluoride membrane (Roche, Indianapolis,
IN, USA), and blocked with Roti-Immunoblock for 2 h or
overnight at 4◦C. The membranes were then incubated with
the desired antibody (Table 1) overnight at 4◦C. Membranes
were subsequently washed 3× PBS/0.1% Tween 20 followed
by incubation with an HRP-conjugated antibody raised in the
appropriate animal (1:2000 dilution; Amersham Biosciences) for
another 30 min. Binding was detected on X-ray films using
an ECL detection system for HRP (Perkin-Elmer, Boston, MA,
USA). Films were developed in a Curix 60 developing machine
(Agfa, Cologne, Germany). After the first detection membranes
were washed in PBS/0.1% Tween for 5 min, then washed in
0.5 NaOH for 10 min, washed again in PBS/0.1% Tween for 5 min
and blocked again and detected with a second/third primary
antibody as described before.
Brain Dissection and Microbiopsies
After sacrificing the bird, the forebrain was quickly dissected,
the hemispheres separated, embedded in TissueTec and frozen
on dry ice. Hemispheres were stored at −80◦C until further
processing. Area X microbiopsies were punched as described
previously (Olias et al., 2014; Adam et al., 2016). Protein was
extracted from pooled microbiopsies of the same animal after we
had confirmed correct targeting of the desired brain region (Olias
et al., 2014; Adam et al., 2016).
Luciferase Promoter Reporter Assay
For SV40 we seeded ∼30000 HeLa cells in 200 µl DMEM
medium (GIBCO) containing Penicillin-Streptomycin (Lonza-
DE17–602E, 10 UI/ml) per well of a 96-well white flat bottom
plate (Nunclon, Cat.No.136101, Denmark). Transfection was
performed using LipofectamineTM 2000 (Invitrogen) following
manufacturer’s protocol. Briefly, after seeding plates were
incubated for 24 h at 37◦C at 5% CO2. For transfection,
the medium was exchanged with 100 µl of antibiotic free
medium before adding the 50 µl transfection mix in each well.
Transfection mix consisted of two parts: (a) 25 µl of OptiMEM
(GIBCO) containing 30 ng of pGL4.13 (Luciferase gene driven
by the SV40 promoter which is known to be regulated by FoxP
subfamily members) and 30 ng of pGL4.75 (Renilla gene driven
by the CMV promoter that is not affected by FoxP subfamily
members, used for normalization of expression changes) and
250 ng total vector over-expressing the different FoxPs for each
well; and (b) 1 µl of LipofectamineTM 2000 (Invitrogen) in
25 µl OptiMEM that was premixed for 5 min at RT. After
combining (a) and (b) the mix was incubated for 20 min at
RT, then it was added to the cells. After 4–6 h of incubation
we changed the medium to 75 µl of antibiotic containing
medium and incubated for further 48 h at 37◦C in a CO2
incubator.
For VLDLR and CNTNAP2 we used HeK293 cells,
and luciferase assays were done as described previously
TABLE 1 | Antibodies.
Antigen Immunogen Manufacturer, species raised in,
mono/polyclonal, Cat. no.
Dilutions
Beta-actin A slightly modified synthetic
b-cytoplasmic actin N-terminal peptide
DDDIAALVIDNGSGK
conjugated to KLH
Sigma, mouse monoclonal, A5441 1:250000-500000 Western blot
FLAG-M2 DYKDDDDK FLAG epitope Stratagene (Agilent), mouse monoclonal,
200471
1:2000-10000 Western blot/8 µg CoIP
Myc EQKLISEEDL tag
human c-Myc, AA 410-419
Roth, rabbit polyclonal, 4667.1 1:2000-10000 Western blot/8 µg CoIP
V5 GKPIPNPLLGLDST Life Technologies, mouse monoclonal, R960-25 1:2000-10000 Western blot
FoxP1 Full length native protein, purified from mouse FOXP1 Abcam, mouse monoclonal, ab32010 1:2000-5000 Western blot/8 µg CoIP
FoxP2 Synthetic peptide (C) REIEEEPLSEDLE corresponding to
amino acids 703-715 of the C-terminus of human FOXP2
Abcam, rabbit polyclonal, ab16046 1:2000-5000 Western blot/8 µg Co-IP
FoxP4 The epitope recognized by A302-394A maps to a region
between residue 1 and 50 of human forkheadbox P4 using
the numbering given in entry NP_001012426.1.
Bethyl, rabbit polyclonal, A302-394A 1:2000-5000 Western blot/8 µg Co-IP
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(Adam et al., 2016). Depending on the promoter, we performed
between 4 and 7 luciferase assays, each after an independent
transfection. Within each assay we used triplicates, e.g., three
wells containing the same transfection reagents and quantity of
cells. The mean of the triplicate was used for statistical analysis.
Each plate was measured once in the ELISA reader.
We measured luminescence using the Dual Glo Luciferase
Kit (Promega) following manufacturer’s protocol in an Elisa
plate reader (Tecan, GENios; Switzerland). Mean background
from untransfected wells was subtracted from all other wells.
We present Luciferase results as mean Relative Light Units
(Luciferase RLU/Renilla RLU) calculated from the normalized
values of 4–7 independent assays.
Cloning of VLDLR and CNTNAP2
Promoters
The pGL4-VLDLR promoter was cloned as described (Adam
et al., 2016). The CNTNAP2 promoter was cloned using
DNA obtained from a blood sample of an adult bird as the
template and amplified with the forward primer 5′-TTG
CCTCATTGATTGCAGAA-3′ and reverse primer 5′-CCTGC
TTTTCTCCACTTTGG-3′ using High Fidelity Taq (Fermentas
K0191). The resulting PCR product was examined on an
agarose gel, cleaned from nucleotides with the Nucleo Spin
Gel and PCR Clean-up (Macherey-Nagel, Germany, Ref
740609.250), and cloned into the pCR4Blunt-TOPO vector of
the Zero blunt PCR cloning kit (Invitrogen) according to the
manufacturer’s protocol. Inserts from three independent
CNTNAP2 clones were fully sequenced to confirm the
sequence of the promoter region of CNTNAP2. Zebra finch
CNTNAP2 sequences were deposited to GenBank, accession
number NCBI KX943238. We then used forward primer
5′-GATGCTAGCTTGCCTCATTGATTGCAGAA-3′ and
reverse primer 5′-GATAGGCCTCCTGCTTTTCTCCACT
TTGG-3′ and subcloned the PCR product into the NheI and
StuI sites of the pGL4.13 vector to generate the pGL4-CNTNAP2
vector used in Luciferase assays.
We identified putative CpG islands in the
CNTNAP2 promoter with the CpG plot tool2. We calculated the
GC percentage in the GC rich region of the promoter region of
CNTNAP2 using the CpG island calculator3.
Overexpression and Transfection of
HeK293 Cells
Overexpression vectors of FoxP1/2/4 tagged with FLAG or
V5 were previously generated (Haesler et al., 2004; Mendoza
et al., 2015). For the generation of Myc tagged FoxP2 we used the
FoxP2-V5 tagged sequence as a template and used the forward
primer 5′-CGCGGATCCGCCACCATGATGCAGGAATCTGC
GACAG-3′ and reverse primer 5′-GCGGAATTCCTACAGAT
CCTCTTCTGAGATGAGTTTTTGTTCTTCCAGATCTTCAG




Electrophoretic Mobility Shift Assays
(EMSA)
Proteins for electrophoretic mobility shift assays (EMSAs) were
purified using the Protino Ni-NTA Agarose (Macherey-Nagel,
Germany, 745400.25) according to manufacturer’s protocol.
Protein was quantified using BCA1 (Sigma). EMSA assays
were carried out as published previously, using the Oligo
described for VLDLR (Adam et al., 2016). The oligo we used for
CNTNAP2 was 5′-TATTATTATTTATTTTTGTACTCTACA
TTCCTTGTTATTTGATACT-3′ (in bold presumed FoxP
binding sites containing the ATTT core sequence).
Statistical Analysis
Statistical tests were performed using the data analysis software
R (R Core Team, 2013). After testing for normality, differences
between Luciferase experiments were calculated with an analysis
of variance (ANOVA) and a Tukey’s HSD post hoc test
for pairwise comparison (R Core Team, 2013). Graphs were
prepared with GraphPad Prism 4.0 (GraphPad Software,
San Diego, CA, USA). Data are expressed as mean of
means± SEM.
RESULTS
FoxP1/2/4 Zebra Finch Proteins Homo-
and Hetero-Dimerize in Cell Lines
To determine whether zebra finch FoxP1/2/4 can homo- and
hetero-dimerize in cell lines, as described for the mouse
FoxPs (Li et al., 2004a) and human FOXPs (Sin et al., 2015),
we transiently overexpressed full length constructs of zebra
finch FoxPs tagged either with FLAG or V5 in HeK293 cells
and performed co-immunoprecipitation assays. In each Co-IP
experiment we used four protein lysates; empty vector lysate
(control 1), lysate with one of the two proteins to be tested
for co-immunoprecipitation (control 2), another lysate with the
other protein to be tested (control 3), and the lysate containing
both proteins (experimental). Lysates were co-IP’ed with FLAG
antibody, and membranes were first detected with V5 antibodies
and sub-sequentially detected with FLAG antibodies. FLAG
tagged proteins were immunoprecipitated as expected from
lysates containing FLAG-tagged proteins whereas this was
not the case for cells expressing an empty vector, or from
cell lysates containing V5 tagged proteins (Figures 1A–F). In
all experiments we detected a protein co-immunoprecipitated
in lysates co-transfected with two differently tagged FoxPs
(Figures 1A–F), indicating protein-protein interactions of the
co-expressed FoxPs. Lastly, in all cases the supernatant was
mostly depleted of the co-IP’ed protein (Figures 1A–F). From
these results we conclude that zebra finch FoxP1/2/4 homologs
are able to form homo- (Figures 1A–C) and hetero-dimers
(Figures 1D–F) in cell lines.
FoxP1/2/4 Antibodies Are Specific
To examine whether FoxP1/2/4 proteins also interact in
neurons of the zebra finch forebrain, we first characterized
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FIGURE 1 | Western blots after co-immunoprecipitations show that all FoxP1/2/4 zebra finch proteins can homodimerize (A–C) and
heterodimerize (D–F) in vitro. HeK293 cells were transfected with combinations of expression vectors encoding FoxP1/2/4 proteins that were tagged with
FLAG or V5. The FLAG monoclonal antibody was used to immunoprecipitate proteins from cell extracts. Immunoprecipitated proteins were resolved on
SDS-polyacrylamide gels, transferred to nitrocellulose and analyzed by sequential immunoblotting with V5 and FLAG antibodies. In all co-immunoprecipitations
(A–F), from left to the right, the first lane shows the empty vector (E.V.) as a negative control; lanes 2 and 3 show protein extracts of transfections with only
one of the two tagged proteins as further controls; lane 4 shows the protein extract from transfection with both proteins. The upper panels show the
V5 detection, and the lower panels the subsequent FLAG detection. For all conditions and detections we show the input proteins, co-immunoprecipitated
proteins and the supernatant after co-immunoprecipitation. In all cases, there is a V5 protein co-immunoprecipitated with the FLAG antibody in the lane
where both proteins are present and a reduction of the co-immunoprecipitated protein in the supernatant, showing an interaction of both proteins marked
with an asterisk (∗).
commercial antibodies against FoxP1/2/4 zebra finch proteins
by over-expressing them individually in HeK293 cells and
performing Western Blots. Specific antibodies show a band of
about 80 kDa molecular weight in each case. Each antibody only
recognized one FoxP (Figures 2A–C, top panel), and not the
other two. The faint bands in the FoxP1 and FoxP2 lanes in
panel c do not correspond to cross reactivity of FoxP4 antibody
against FoxP1 and FoxP2 protein, which have a slightly
different molecular weight, as can be seen in the FLAG tagged
versions (middle panel). The subsequent detection with FLAG
(and actin antibodies, lower panel) also demonstrates that
over-expressed proteins were present in the protein lysate
in similar quantity (Figures 2A–C). From these results we
conclude that antibodies are specific for the different zebra finch
FoxPs.
FoxP1/2/4 Zebra Finch Protein
Hetero-Dimerize in the Brain
We performed co-IP assays on protein lysates of adult male zebra
finch forebrain using the specific antibodies described above.
FoxP1 monoclonal antibody was not able to pull down the non-
denatured, native brain protein (data not shown), and therefore
we used FoxP2 and FoxP4 polyclonal antibodies to pull down
protein complexes, and all three antibodies for Western blot
detection. As a negative control we used IgG antibodies of the
same species in which the specific FoxP antibodies were raised.
After IP with FoxP2 or FoxP4 antibodies, we detected co-IP’ed
FoxP1 (Figures 3A,B). After IP with FoxP2 we detected co-
IP’ed FoxP4 (Figure 3C). In contrast, no protein of the expected
size was precipitated with IgG controls (Figures 3A–C). From
these results we conclude that FoxP1/2/4 form hetero-dimers
in forebrain neurons in vivo. To our knowledge this is the first
report showing that FoxP1/2/4 proteins can form hetero-dimers
in the brain.
FoxP1/2/4 Zebra Finch Proteins form an
Oligomer in a Cell Line
Since the majority of FoxP expressing cells in Area X
and the surrounding striatum express FoxP1/2/4 (Mendoza
et al., 2015), and since it is known that FOXP3 is able
to homo-oligomerize and hetero-associate in cell lines (Li
et al., 2007; Song et al., 2012), we wanted to assess whether
all three neurally expressed FoxP proteins could bind in a
single protein complex. To test this we performed double
co-IP from HeK293 cell lysates co-transfected with full length
FoxP1-FLAG, FoxP2-Myc and FoxP4-V5 tagged zebra finch
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FIGURE 2 | Western blots demonstrating the specificity of the different FoxP antibodies by detecting only one FoxP protein in extracts of
HeK293 cells transfected with an over-expression vector carrying either empty vector (E.V.), or the three FLAG-tagged FoxP proteins. Proteins were
resolved by SDS-PAGE, transferred to nitrocellulose, and first detected (top panels) with anti-FoxP1 (A), or anti-FoxP2 (B), or anti FoxP4 (C) and sequentially
detected FLAG/b-actin antibodies as loading controls (middle panels) (A–C). Bottom panels show detection of actin in the samples as a loading control. In all cases,
the specificity of the antibody is evident from a single band in the expected lane (∗).
FIGURE 3 | FoxP1/2/4 can hetero-dimerize in the brain. The three panels depict representative co-immunoprecipitation experiments from nuclear protein
extracts of adult zebra finch brains with anti-FoxP2 (A,C), anti-FoxP4 (B), or nonspecific IgG (A–C) under non-denaturing conditions. Proteins were resolved by
SDS-PAGE, transferred to nitrocellulose, and analyzed by sequential immunoblotting with anti-FoxP1 (A-left and B-right, Westerns), or anti-FoxP2 (A,C left
Westerns), or anti FoxP4 (B,C right panels). In all cases, a hetero-dimer was co-immunoprecipitated with the specific antibodies from whole forebrain lysate and no
signal of the same size was detected in the IgG control, suggesting an interaction of FoxP proteins.
proteins (Figure 4A schematic). If FoxP1/2/4 were not able
to hetero-associate in a complex after double co-IP we should
only detect the two proteins that were immunoprecipitated,
but if they hetero-associate in a complex we should be able
to detect all three FoxPs. We first immunoprecipitated with
Myc, to pull down FoxP2 and all proteins bound to it.
After the first immunoprecipitation we found that all three
proteins had co-IP’ed (Figure 4B). The fact that we detected
FoxP1-FLAG and FoxP4-V5 after immunoprecipitating the
Myc-taggd FoxP2 could be due to pulled down hetero-dimers of
FoxP2 with FoxP1 or with FoxP4. Alternatively, FoxP1/2/4 could
have been simultaneously pulled down by immunoprecipitating
Myc-tagged FoxP2. To assess this, a second, sequential IP with
FLAG was carried out to detect FoxP1-FLAG after the first IP.
After the second immunoprecipitation we detected not only
FoxP1-FLAG but also co-IP’ed FoxP4-V5 (Figure 4, upper
blot).
Not all protein was depleted from the first supernatant,
one possible explanation being that FoxP1 homodimers
and FoxP4 homodimers were not precipitated by Myc
antibodies detecting FoxP2-Myc. Leftover FoxP2 in the
supernatant additionally indicates that not all FoxP2 was
precipitated by the Myc antibody, likely because of insufficient
antibody concentration to deplete all FoxP2 protein and its
associated interaction partners. No protein was detected after
the second immunoprecipitation in the second supernatant
(Figure 4, S2).
In summary, these data suggest that FoxP1/2/4 can form a
complex including all three proteins, a result which has not
been reported before. In addition to this hetero-oligomerization,
we also found homo- and hetero-dimerization of all FoxPs
(Figures 1, 3).
FoxP1/2/4 Zebra Finch Proteins
Oligomerize In Vivo
To assess whether FoxP1/2/4 can hetero-oligomerize in the
zebra finch song system we used nuclear protein extracts
of Area X. Double IP using specific antibodies detected the
three proteins in the co-immunoprecipitated fraction suggesting
that FoxP1/2/4 can also hetero-associate in vivo in Area X
(Figure 5).
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FIGURE 4 | FoxP1/2/4 zebra finch proteins can oligomerize in vitro. (A) Schematic representation of possible combinations of dimers (left panel) or a multimer
(right panel) of FoxP1/2/4 in IPs. (B) Western blots of double-immunoprecipitation of HeK293 cells transfected with combinations of expression vectors encoding
FoxP1 FLAG-tagged, FoxP2 Myc-tagged, and FoxP4 V5-tagged proteins, revealing a FoxP1/2/4 multimer. The left panel of the Western blot shows, from left to right,
in the first lane the input protein extract after transfection with all three proteins, followed by lane 2 showing the immunoprecipitated FoxP2-Myc (lower panel,
asterisk) with the co-immunoprecipitated FoxP1-FLAG and FoxP4-V5 (upper panel, asterisk). Lane 3 shows the absence of immunoprecipitated proteins when using
IgG (rabbit), lane 4 shows the subsequent immunoprecipitation of FoxP1-FLAG (upper panel, asterisk) and co-immunprecipitated FoxP4 and FoxP2 (upper and
lower panels respectively, asterisks). In the right Western blot the first lane is again the input, followed by the supernatant of the first immunoprecipitation with Myc
and IgG rabbit in lanes 2 and 3, and then the supernatant of the subsequent immunoprecipitation with FLAG.
FIGURE 5 | Hetero-oligomerization of FoxP1/2/4 occurs in the brain, in
song nucleus Area X. Co-immunoprecipitation performed on nuclear protein
extracts from microbiopsies of Area X. The protein extract was split into equal
amounts. One was immunoprecipitated with FoxP2 antibody and
subsequentially with FoxP4 antibody, the other half was immunoprecipitated
with rabbit IgG two times sequentially. Immunoprecipitated proteins were
resolved on SDS-polyacrylamide gels, transferred to nitrocellulose, and
analyzed by sequential immunoblotting with FoxP2 and FoxP4 or
FoxP1 antibodies.
FoxP1/2/4 Zebra Finch Proteins Repress
the SV40 Promoter in Luciferase Promoter
Reporter Assays
We assessed whether the homotypic and heterotypic interaction
of zebra finch FoxP proteins lead to differential regulatory
activity. To do so we used the SV40 promoter driving Luciferase
(Photinus pyralis synthetic protein). The SV40 promoter has
a putative core consensus sequence for binding (TATTTRT)
human and murine Foxp1/2/4 (Wang et al., 2003; Vernes et al.,
2006). For the human and mouse proteins it was shown in
luciferase promoter reporter assays that each FoxP can repress
the SV40 promoter individually (Wang et al., 2003; Li et al.,
2004a; Vernes et al., 2006). Likewise, we found that zebra
finch FoxP proteins when expressed individually in HeLa cells
significantly repressed the transcriptional activity under the
control of the SV40 promoter (Figure 6; One way ANOVA;
F = 28.79; DF = 7; n = 8; p< 0.0001; Tukey’s Multiple comparison
Test; compared to empty vector: FoxP1 p < 0.0001, FoxP2
p = 0.013, and FoxP4 p < 0.0001), in the same range as reported
for mice and human FOXP1/2/4. Also, like its mammalian
homologs, zebra finch FoxP4 repressed transcription stronger
than FoxP1 or FoxP2 did, and FoxP2 was a weak repressor of
the SV40 promoter (Wang et al., 2003; Li et al., 2004a; Vernes
et al., 2006). Cells expressing combinations of the different
FoxP subfamily members also showed a significant repression
of the SV40 promoter (compared to empty vector: FoxP1/2
p < 0.0001; FoxP1/4 p < 0.0001; FoxP2/4 p < 0.0001 and
FoxP1/2/4 p = 0.0001). There were no significant differences
between cells expressing FoxP1 or FoxP4 alone or in any of the
combinations tested. We did observe a stronger transcriptional
repression in cells expressing FoxP2 in combination with another
FoxP subfamily member than when FoxP2 was expressed
alone (compared to FoxP2 alone: FoxP1/2 p = 0.016; FoxP2/4
p = 0.0005 and FoxP1/2/4 p < 0.0001). However, we cannot
rule out the formation and action of homodimers of FoxPs in
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FIGURE 6 | Luciferase assays demonstrate transactivation properties
of different combinations of FoxP1/2/4 proteins on the SV40 promoter.
FoxP1/2/4 as well as their combinations significantly repressed the
pGL4.13-promoter transcriptional activity through a specific DNA-binding site
in the SV40 promoter. Significance levels from all combinations to the empty
vector control are represented by stars, ∗∗p < 0.001–0.01; ∗∗∗p < 0.001. One
way ANOVA; F = 28.79; DF = 7; n = 8; followed by Tukey’s multiple
comparison test; Bars show mean of means ± SEM of five independent
transfections for each of the eight conditions, presented as luciferase/renilla
ratio (RLU), corrected for transfection by pGL4.75 Renilla luciferase activity.
1x = 125 ng of overexpressing vector per well, 2x = 250 ng of overexpressing
vector per well. The control transfection value was obtained with the empty
expression vector (pcDNA3.1).
those cells. Taken together, FoxP target genes in cells that express
only FoxP2 may be less strongly regulated than those that are
co-expressed with FoxP1 and/or FoxP4.
VLDLR Is a Direct Target Not Only of
FoxP2 but Also of FoxP1/4
To explore whether FoxP proteins not only regulate SV40 but
also neurally relevant promoters we chose VLDLR for a number
of reasons: (a) it is a direct target of FoxP2 in humans, mice,
and zebra finches (Spiteri et al., 2007; Vernes et al., 2007; Adam
et al., 2016); (b) both FoxP2 and VLDLR promote dendrite
and dendritic spine development in various species (Niu et al.,
2004, 2008; Schulz et al., 2010; Vernes et al., 2011); and (c) in
songbirds, FoxP2 and VLDLR are expressed in Area X and
the basal ganglia (Balthazart et al., 2008; Hilliard et al., 2012)
and are co-regulated in different contexts (singing, age and
by molecular manipulations; Adam et al., 2016). Most of the
work on target genes in the FoxP subfamily that are expressed
in the brain have focused on FoxP2, and it is not known
how much overlap there is in the binding sites for FoxP1 and
FoxP4 and whether they can bind to the same promoter motives.
To investigate this we used the VLDLR-oligonucleotide that
FoxP2 can bind to in EMSA (Adam et al., 2016) and tested
whether FoxP1/4 also binds to this probe. The protein extract
of HeK293 cells transfected with empty vector (mock extract)
presented a non specific shift (n.s.; Figures 7A,B, first lane).
In the presence of FoxP1 or FoxP4 a specific shift of the
DNA was observed, indicating that both proteins are able to
bind to the VLDLR oligonucleotide (Figure 7A,B, second lane).
Addition of a specific competitor diminished the intensity of
this band (Figure 7A,B, third lane). Adding a V5 antibody
to the FoxP/oligonucleotide mix resulted in a further shift,
strengthening the notion that that FoxP1 or FoxP4 generated the
shift (Figure 7A,B, fourth lane). From these results we conclude
that FoxP1 and FoxP4 can bind to the same VLDLR region that
FoxP2 binds to, suggesting that all three FoxPs share a common
target gene.
FoxP1/2/4 Differentially Activate the
VLDLR Promoter in Luciferase Promoter
Reporter Assays
To test whether binding of FoxP1/2/4 to the VLDLR promoter
leads to an alteration of transcription, we performed luciferase
assays using the pGL4-VLDLR vector described previously
(Adam et al., 2016). There were significant differences in
activation of the VLDLR promoter depending on the specific
combinations of FoxP proteins (One way ANOVA; F = 26.09;
DF = 7 and n = 8; p < 0.0001; Figure 7C). Tukey’s Multiple
comparison Test revealed that when compared to empty vector,
FoxP1 was a significantly better activator of the VLDLR promoter
than FoxP2 or FoxP4 (FoxP1 p < 0.0001, FoxP2 p < 0.007 and
FoxP4 p = 0.0024). However, FoxP2 and FoxP4 were less effective
and not significantly different from each other in their ability
to activate the VLDLR promoter (p = 0.999). Combinations
of FoxP1/2/4 did activate the VLDLR promoter to a similar
degree (compared to empty vector: FoxP1/2 p< 0.0001; FoxP1/4
p < 0.0001; FoxP2/4 p = 0.0003 and FoxP1/2/4 p < 0.0001).
Comparing the activation of FoxP2 alone to the FoxP1/2 and
FoxP1/2/4 combination (p = 0.0078 and p = 0.012 respectively)
we found a significant difference on the VLDLR promoter but
not with the FoxP2/4 combination (p = 0.88). There were no
differences between the individual activation by FoxP4 and the
combinations with FoxP1 (p = 0.10) or FoxP2 (p = 0.98), but
there was a significant difference to the FoxP1/2/4 combination
(p = 0.034). Taken together FoxP1/2/4 are not only repressors,
but are able to bind to the VLDLR promoter and activate
it differently depending on the co-expression with other
FoxPs.
Closing the Gap of the CNTNAP2 Zebra
Finch Promoter
To further test the regulatory ability of zebra finch FoxPs on
a target gene relevant in Area X, we chose CNTNAP2 because:
(a) CNTNAP2 is associated with speech disorders, as well as
ASD, dyslexia and intellectual disability (Rodenas-Cuadrado
et al., 2014) some of which are also associated with FoxP
mutations (MacDermot et al., 2005; Vargha-Khadem et al., 2005;
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FIGURE 7 | FoxP1/2/4 bind and activate the very low density lipoprotein receptor (VLDLR) promoter. DNA binding assays with FoxP1 (A) and FoxP4
(B). Nuclear extracts (1 µg) from HeK293 cells were incubated with the digoxigenin labeled probe (0.8 ng) representing the 27-bp of the VLDLR FoxP2 binding site.
Shown in each case are protein lysate of HeK293 cells transiently transfected with empty vector and labeled probe (lane 1), shift in the presence of nuclear extract of
FoxPs (lane 2), and complex formation in the presence of 200-fold molar excess of specific un-labeled probe (lane 3) and supershift in the presence of labeled probe,
FoxPs protein extract and monoclonal V5 antibody (1 mg/ml; lane 4). In all cases arrows point to free oligo, non specific shift (n.s.), FoxP shift and supershift.
(C) Luciferase assays were carried out in HeK293 cells to measure effects of a FoxP1/2/4 alone or in combinations on the VLDLR promoter. Significance levels from
all combinations to the empty vector control are represented by asterisk, ∗∗p < 0.001–0.01; ∗∗∗p < 0.001. One way analysis of variance (ANOVA); F = 26.09;
DF = 7 and n = 8; followed by Tukey’s multiple comparison. Bars show mean of means ± SEM of four independent transfections, presented as luciferase/renilla ratio
(RLU), corrected for transfection by pGL4.75 Renilla luciferase activity. 1x = 125 ng of overexpressing vector per well, 2x = 250 ng of overexpressing vector per well.
The control transfection value was obtained with the empty expression vector (pcDNA3.1).
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Shriberg et al., 2006; Zeesman et al., 2006; Lennon et al., 2007;
Pariani et al., 2009; Vernes et al., 2009; Carr et al., 2010; Hamdan
et al., 2010; Horn et al., 2010; Bowers and Konopka, 2012; Rice
et al., 2012; Žilina et al., 2012; Chien et al., 2013; Le Fevre et al.,
2013; Palumbo et al., 2013; Toma et al., 2013); (b) CNTNAP2
is a direct target of Foxp2 in mice and of FOXP1 in humans
(Vernes et al., 2007; O’Roak et al., 2011); (c) FoxP1/2/4 and
CNTNAP2 are expressed in Area X and the basal ganglia in
zebra finches (Haesler et al., 2004; Panaitof et al., 2010; Condro
and White, 2014; Mendoza et al., 2015); and (d) FoxP2 binds
to the CNTNAP2 promoter region in zebra finches and the
expression of both is correlated in adult undirected singing and in
non-singing juveniles as well as after FoxP2 lentiviral knockdown
(Adam et al., in review; personal communication).
The assembled genome region of the zebra finch CNTNAP2
promoter contained a sequence gap located ∼0.75 kb upstream
of the start codon of the first exon of CNTNAP2 (Figure 8A).
We cloned and sequenced across the gap, identifying a 462bp
fragment, which had a high GC-content of up to 79.50% and was
within the CpG island. The CpG island was located∼0.83–1.2 kb
upstream of the star codon of the first exon. A TATA box was
identified∼20 bp of the transcription start site (TSS). This region
had 11 FoxP2 binding sites (Figure 8A, red shapes; Pierrou et al.,
1994; Stroud et al., 2006; Nelson et al., 2013), four located in the
promoter region and 7 in the 5′ UTR region. We were able to
close the gap in the genome enabling us to further investigate the
previously incomplete CNTNAP2 promoter sequence and use it
for luciferase assays.
EMSA Reveals that FoxP1/2 Bind to the
CNTNAP2 Promoter but FoxP4 Does Not
We used an oligonucleotide probe from a sequence in the 5′ UTR
region of the zebra finch CNTNAP2 (Figure 8A) to test whether
FoxP1/2/4 bind to it. This oligomer was identified in a parallel
study on FoxP2 and CNTNAP2 interactions interactions (Adam
et al., in review). FoxP1 was able to bind to the CNTNAP2 oligo
and resulted in two shifted bands, consistent with the possibility
that it binds in two of the three FoxP2 binding sites (Pierrou
et al., 1994; Enard et al., 2009; Nelson et al., 2013) contained in
the oligo (Figure 8B, ‘‘Materials and Methods’’ Section). We also
confirmed the results of Adam et al. (in review), showing that
FoxP2 also binds (Figure 8C). Interestingly, FoxP4 did not result
in a DNA shift in the EMSA (Figure 8D).
FoxP1 Activates, FoxP2 Represses and
FoxP4 Does Not Regulate the CNTNAP2
Promoter in Luciferase Promoter Reporter
Assays
To investigate whether binding of FoxP1 and FoxP2 to the
CNTNAP2 promoter leads to an alteration of transcription, we
performed luciferase assays using the pGL4-CNTNAP2 vector
(Figure 8E). When tested individually, FoxP1 activated the
CNTNAP2 promoter and FoxP2 repressed it. As expected from
the lack of binding ability of FoxP4 to the CNTNAP2 promoter
oligo (Figure 8D) FoxP4 failed to regulate the CNTNAP2
promoter in the Luciferase assay (Figure 8E; One way ANOVA;
F = 21.66; DF = 7 and n = 8; p < 0.0001; Tukey’s
Multiple comparison Test; compared to empty vector: FoxP1
p = 0.005, FoxP2 p < 0.0001 and FoxP4 p = 0.91). Moreover,
in combination, the different FoxPs also failed to regulate
expression driven by the CNTNAP2 promoter, (compared to
empty vector: FoxP1/2 p = 0.26; FoxP1/4 p = 0.28; FoxP2/4
p = 1 and FoxP1/2/4 p = 0.22). Interestingly, combinations of
FoxP4 with either FoxP1 or FoxP2 did not result in repression or
activation, in contrast to FoxP1 or FoxP2 alone, suggesting that
hetero-dimerization might affect the regulation of FoxPs. Taken
together we show that FoxP1 and FoxP2 can bind to and regulate
the CNTNAP2 promoter, with opposing activities. CNTNAP2 is
an example of how FoxPs may tune the regulation of different
targets genes via homo- and hetero-dimerization.
DISCUSSION
The present study demonstrates for the first time that FoxP
proteins can not only dimerize in cell lines, as previously shown
for mice (Li et al., 2004a) and humans (Sin et al., 2015), but also
in the brain. Moreover, we discovered that FoxP proteins can also
oligomerize, in cell lines and in the brain, also a novel finding.
Specifically, we show that FoxP1/2/4 proteins can associate
with each other in Area X, a song nucleus relevant for vocal
learning, whose function depends on adequate FoxP2 protein
amounts (Miller et al., 2008; Thompson et al., 2013). In
addition, we compared the potential of the neurally expressed
FoxP proteins to bind to the regulatory regions of SV40,
VLDLR andCNTNAP2 and regulate their transcriptional activity.
Zebra finch FoxP1/2/4 repressed the SV40 promoter activity,
as reported for mouse and human (Wang et al., 2003; Vernes
et al., 2006). In contrast, FoxP1/2/4 all activated the VLDLR
promoter. Interestingly, the CNTNAP2 promoter was regulated
differentially; whereas FoxP1 activated it, FoxP2 repressed it and
FoxP4 neither bound nor regulated this promoter. Together,
these results emphasize the functional importance of the protein-
protein interactions among the FoxP subfamily members in
regulating their target genes. Since we previously showed that
FoxP1/2/4 are expressed in different combinations in the MSN
of the basal ganglia, including Area X (Mendoza et al., 2015), the
present findings provide important steps toward understanding
how the combinatorial regulation of FoxP2 with its interaction
partners may regulate neural function in a circuit relevant for
vocal production learning, such as speech in humans and song
in birds.
Our findings that different combinations of FoxP1/2/4 can
activate the promoter for the reelin receptor VLDLR with
different strengths are likely to have consequences for spine
formation and synaptic transmission in a neuron-specific way,
which would facilitate a fine-tuning of VLDLR regulation in Area
X MSNs. This is consistent with data in mice and songbirds
(Schulz et al., 2010; DiBattista et al., 2015; Adam et al., 2016).
In addition, given that the cellular levels of FoxP2 vary notably
with age, song stereotypy, and singing (Haesler et al., 2004;
Teramitsu and White, 2006; Miller et al., 2008; Thompson
et al., 2013) but FoxP1 and FoxP4 do not (Mendoza et al.,
2015) it would be interesting to investigate the consequences of
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FIGURE 8 | FoxP1 activated, FoxP2 repressed and FoxP4 did not bind or regulate the Contactin-associated protein-like 2 (CNTNAP2) promoter.
(A) Schematic of the CNTNAP2 promoter region. Arrows show the region of the primers used to clone the CNTNAP2 promoter region. The location of the predicted
transcription start site (TSS), TATA-box, CpG island (blue box), GAP (white box), 5′ UTR (gray box), coding sequence (CDS, black box) and FOXP2 binding sites (red
shapes) are denoted by lines. The fragment used for the EMSA experiments (described in Adam et al., in review) is illustrated by the vertical line labeled “EMSA oligo”
on the 5′ UTR region. DNA binding assays with FoxP1 (B), FoxP2 (C) and FoxP4 (D) with the CNTNAP2 oligo. Nuclear extracts (1 µg) from HeK293 cells were
incubated with the digoxigenin labeled probe (0.8 ng) representing the 46-bp of the CNTNAP2 FoxP2 binding site. Shown in each case are protein lysate of
HeK293 cells transiently transfected with empty vector and labeled probe (lane 1), shift in the presence of nuclear extract of FoxPs (lane 2), and complex formation in
the presence of 200-fold molar excess of specific un-labeled probe (lane 3) and supershift in the presence of labeled probe, FoxPs protein extract and monoclonal
V5 antibody (1 mg/ml; lane 4). In all cases arrows point at free oligo, non specific shift (n.s.), FoxP shift and supershift. (E) Luciferase assays were carried out in
HeK293 cells to measure effects of FoxP1/2/4 alone or in combinations on the CNTNAP2 promoter. Significance levels from all combinations to the empty vector
control are represented by asterisks, ∗∗p < 0.001–0.01; ∗∗∗p < 0.001. One way ANOVA; F = 21.66; DF = 7 and n = 8; followed by a Tukey’s multiple comparison
test. FoxP1 and FoxP2 single transfections significantly activated or repressed the pGL4-CNTNAP2 transcriptional activity through a specific DNA-binding site in the
CNTNAP2 promoter (One way ANOVA; Tukey’s multiple comparison test; ∗∗P < 0.005; ∗∗∗P < 0.0001). FoxP4 as well as all other combinations did not regulate the
CNTNAP2 promoter. Bars show mean of means ± SEM of seven independent transfections presented as luciferase/renilla ratio (RLU), corrected for transfection by
pGL4.75 Renilla luciferase activity. 1× = 125 ng of overexpressing vector pro well, 2× = 250 ng of overexpressing vector per well. The control transfection value was
obtained with the empty expression vector (pcDNA3.1).
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dimerization with FoxP1 and FoxP4 on target gene regulation
in the situations when FoxP2 levels vary. In Bengalese finches,
FoxP2 mRNA levels as detected by in situ hybridization are
also down regulated by singing, but down regulation was not
observed for FoxP1 levels (Chen et al., 2013).
The present data on the regulation of CNTNAP2 by
FoxP1/2/4 are interesting in light of the differential activation
and repression of target genes by FoxP2 (Vernes et al., 2007).
In human SH-SY5Y cells FOXP2 represses CNTNAP2 (Vernes
et al., 2008). In our experiments, HeK293 cells transfected
with zebra finch FoxP2 also repressed the CNTNAP2 promoter
activity. In contrast, FoxP1 activated the CNTNAP2 promoter.
FoxP4 did not bind and, as expected, did not regulate
the CNTNAP2 promoter. Of note, when we co-transfected
FoxP1/4 or FoxP2/4 there was no significant difference in
CNTNAP2 promoter driven reporter gene activity, suggesting
that the presence of FoxP4 prevents regulation by both
FoxP1 and FoxP2, even though when present alone, they activate
or repress, respectively. This type of differential transcriptional
regulation by FOXP proteins has been described for a number of
different target genes in Hek293 cells (Sin et al., 2015). In the case
where the two components of a dimer have opposing functions
when expressed alone, the most parsimonious explanation is that
the activation (FoxP1) and the repression (FoxP2) cancel each
other out in the reporter assay, but other scenarios are of course
possible.
In the brain, CNTNAP2 is also co-expressed in MSN of
Area X in zebra finches (Panaitof et al., 2010; Condro and
White, 2014). The mRNA amounts of FoxP2 and CNTNAP2
in this song nucleus of juvenile male finches and in singing
adults are positively correlated. Interestingly, in a zebra finch
cell line (Itoh and Arnold, 2011) zebra finch FoxP2 activated the
CNTNAP2 promoter (Adam et al., in review), which is in the
opposite direction of the present findings with HeK293 cells. This
highlights the plasticity with which FoxP proteins can regulate
target genes in different cellular contexts, depending on different
binding of co-factors that change the regulation of the same gene
(Diamond et al., 1990).
Our data underscore the need to take di- and oligo-merization
of the different FoxP proteins more into consideration when
trying to understand how mutations of FOXP1 (Hamdan et al.,
2010) and FOXP2 (Lai et al., 2001) cause disease. Sin et al. (2015)
and the present data show that different FoxP proteins can share
the same target gene, but that different combinations of proteins
can result in opposite effects. It is therefore easily imaginable that
a mutation in FoxP1 or FoxP2 could have different effects on
the target genes in different neuron types, depending on which
other FoxP proteins are co-expressed in the particular cell type
(Haesler et al., 2004; Teramitsu et al., 2004; Bowers et al., 2014;
Mendoza et al., 2015). This idea is consistent with data from
cell lines showing that the subcellular localization deficits caused
by FOXP2 mutations can be rescued by co-expression with the
wild-type protein (Mizutani et al., 2007; Vernes et al., 2009).
It has not been tested whether co-expression with FOXP1 or
FOXP4 would have the same effect. If so, it could explain why
some tissues might be much more vulnerable to the effects of
mutations than others.
Our data do not address which type of protein-protein
interaction the homo-and heterodimerization makes use of. FoxP
proteins have (at least) two ways to associate or interact: the
leucine zipper motif and domain swapping, e.g., the exchange
of identical structural elements involving the Forkhead domain
(Stroud et al., 2006; Bandukwala et al., 2011; Chu et al., 2011).
FoxP proteins with mutations in the leucine zipper protein
domain cannot associate (Wang et al., 2003; Li et al., 2004a;
Chae et al., 2006), nor bind to DNA or regulate target genes (Li
et al., 2004a). For FOXP2 and FOXP3 the inability to dimerize
via this domain has also been linked to disorders (Bennett et al.,
2001; Li et al., 2007; Roll et al., 2010). Domain swapping has
been described for FOXP1/2/3 (Stroud et al., 2006; Bandukwala
et al., 2011; Chu et al., 2011) but not so far for FOXP4. It is
not known how dimers or multimers of FoxP proteins interact
with the regulatory regions of the target genes in any species. In
addition, the relative functional importance of associations via
the leucine zipper or via domain swapping has not been resolved.
One important difference between both types of interaction is
that domain swapping has only been reported for FoxP proteins
of the same type and not for hetero-associations. In principle,
these should also be possible, because all FOXPs share the
proline that was reported to be important for domain swapping
(Medina et al., 2016) and that other Fox proteins lack. They
have an alanine amino acid instead at that position (Stroud
et al., 2006; Perumal et al., 2015). In mice the Foxp1/2/4 proteins
need to homo- and hetero-dimerize in order to bind DNA and
regulate the promoter of the murine CC10 gene, relevant for
lung development (Li et al., 2004a). The leucine zipper is a
characteristic feature of the FoxP subfamily and is present also
in all zebra finch FoxP proteins and episodic positive selection of
this domain occurred in some bird species (Mozzi et al., 2016).
Finally, our data are the first to address neural targets
regulated by FoxP1 and FoxP4. We tested the binding of two
known targets of FoxP2 in zebra finches, VLDLR and CNTNAP2.
All zebra finch FoxP proteins studied bound to the VLDLR
oligonucleotide, which was previously shown to bind to FoxP2
(Adam et al., 2016). The VLDLR oligonucleotide contains a
partial FOXP core sequence, ATTT (Stroud et al., 2006) and
a sequence that resembles the FOXP1 consensus sequence,
TTATTTAT (Wang et al., 2003). FOXP2 has similar binding
sites (Vernes et al., 2008; Enard et al., 2009; Nelson et al., 2013).
All FoxPs share the FOX binding site TRTTTAY (Pierrou et al.,
1994). The CNTNAP2 oligonucleotide contains three putative
FoxP2 binding sites. One TATTTAT (Enard et al., 2009), and
two other sites that have the core ATTT mentioned above Stroud
et al. (2006). It is not clear why FoxP4 of zebra finches is not
binding, since it would be expected to bind in the presences of
the full FoxP consensus (TATTTAT) binding site. However, the
binding of FoxP4 is less studied and target genes are not known.
To further validate that these putative binding sites are neurally
and biologically relevant ChIP data are needed.
In summary, we show that zebra finch FoxP proteins can
interact with each other in all combinations in the songbird
brain. We show that all neurally expressed FoxPs have the
capacity to bind to and regulate the target genes VLDLR and
CNTNAP2. Importantly, different FoxP combinations resulted
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in specific, differential transcriptional regulation. Together, our
data demonstrate how versatile and variable FoxP regulation can
be in the neural context.
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